Consumer Reports published testing results on June 11 showing no detectable per- and polyfluoroalkyl substances (PFAS) in any of the 18 baby wipe brands it assessed. Using an EPA-validated testing method capable of detecting PFAS at concentrations as low as 2.3 nanograms per sample, the organization tested for 30 individual PFAS compounds across products including Huggies, Pampers, Kirkland Signature, Coterie, and store-brand options from Amazon and Walmart. None returned a positive detection. The 30 compounds tested represent those most commonly found in consumer products and most associated with documented health risks, drawn from a universe the EPA estimates contains more than 21,000 known PFAS compounds.
The findings carry weight precisely because baby wipes are a high-frequency skin contact product. Researchers in one study estimated infants may have contact with as many as 10,000 wipes in their first three years of life. Babies absorb chemicals through skin more readily than adults: their skin is estimated to be 20 to 30% thinner, and their higher surface-area-to-body-weight ratio amplifies exposure relative to body mass. Hand-to-mouth behavior adds a second route. Two lawsuits filed in 2024 targeting PFAS in baby wipes, one against the maker of Kirkland Signature wipes and one against Kimberly-Clark's Huggies line, reflected that concern, though both have since been dismissed or withdrawn.
No Federal Standard Requires Manufacturers to Test or Disclose
The Consumer Reports result is good news. It is not a regulatory baseline. No federal standard currently requires manufacturers of personal care products, including baby wipes, to test for PFAS or disclose test results publicly. The EPA's TSCA PFAS reporting rule, which opened its submission window in April 2026 after multiple delays, covers PFAS use in industrial and commercial contexts but does not mandate consumer product PFAS testing at the manufacturer level. Compliance teams tracking PFAS product obligations are navigating a patchwork of state laws rather than a unified federal framework. As of January 2026, new PFAS prohibitions and reporting requirements took effect in Colorado, Connecticut, Maine, Minnesota, Vermont, and Washington. Most of these laws target intentionally added PFAS, which means process contamination routes may still fall outside their scope.
The Process Contamination Problem Is What State Bans Don't Fully Address
State bans on intentionally added PFAS have been accelerating. Illinois enacted a broad PFAS ban covering cookware, cosmetics, children's products, personal care items, and food packaging effective in 2026. Connecticut now requires visible labeling and manufacturer notification for products with intentionally added PFAS across a wide category list. But PFAS in personal care products does not always arrive through intentional addition. It can enter as a processing aid during manufacturing, through contaminated raw materials, or via supplier inputs that manufacturers may not independently test. That distinction is what makes voluntary third-party testing the only current mechanism for verifying absence. Consumer Reports noted that its results suggest PFAS contamination is not a systemic issue in the current baby wipes market, but also called on manufacturers to regularly conduct and publicly share their own testing. No manufacturer is required to do so.
For EHS and supply chain teams managing product compliance across multiple categories, the baby wipes result illustrates a broader structural gap: state disclosure laws are expanding, but they are built around intent rather than presence. A product can be fully compliant with current state law and still contain trace PFAS introduced somewhere upstream in the supply chain. 2026 is the first year major state and federal PFAS reporting deadlines are converging. That makes it the right time to build supplier due diligence programs that ask not just whether PFAS was intentionally added, but whether it's actually there.
